Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial

Yong Sang Hong, Byung‐Ho Nam, Kyu-pyo Kim, +6

The Lancet Oncology

Surgical OncologyRadiation TherapyGastrointestinal OncologyMedicineAdjuvant Chemotherapy +7

Oxaliplatin-Based Adjuvant Chemotherapy for Rectal Cancer After Preoperative Chemoradiotherapy (ADORE): Long-Term Results of a Randomized Controlled Trial

Yong Sang Hong, Sun Young Kim, Ji Sung Lee, +18

Journal of Clinical Oncology

ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma

Ivana Yen, Jeeyun Lee, Yong Sang Hong, +35

Nature

Raf Inhibitor BelvarafenibMelanomaPathologyMolecular OncologyCancer Genetics +4

S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: a randomised, non-inferiority phase 3 trial

Yong Sang Hong, Young Suk Park, Ho Yeong Lim, +15

The Lancet Oncology

Gastrointestinal OncologyMedicineColorectal CancerMetastatic Colorectal CancerSurgery +5

Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group

Changhoon Yoo, Hyeon-Su Im, Kyu-pyo Kim, +13

Therapeutic Advances in Medical Oncology

Influence of Ginkgo biloba extract on the pharmacodynamic effects and pharmacokinetic properties of ticlopidine: An open-label, randomized, two-period, two-treatment, two-sequence, single-dose crossover study in healthy Korean male volunteers

Bo‐Hyung Kim, Kyu-pyo Kim, Kyoung Soo Lim, +8

Clinical Therapeutics

Pharmacological StudySingle-dose Crossover StudyMedicineHerb-drug InteractionPharmacotherapy +5

L-Ascorbic acid can abrogate SVCT-2-dependent cetuximab resistance mediated by mutant KRAS in human colon cancer cells

Soo-A. Jung, Dae‐Hee Lee, Jai-Hee Moon, +16

Free Radical Biology and Medicine

Tumor BiologyCell RegulationOncogenic AgentMedicineL-ascorbic Acid +7

Prospective evaluation of the drug-metabolizing enzyme polymorphisms and toxicity profile of docetaxel in Korean patients with operable lymph node-positive breast cancer receiving adjuvant chemotherapy

Kyu-pyo Kim, Jin Hee Ahn, Sung‐Bae Kim, +4

Cancer Chemotherapy and Pharmacology

Breast OncologyMedicinePharmacologyAdjuvant ChemotherapyProspective Evaluation +7

Prospective phase II study of neoadjuvant FOLFOX6 plus cetuximab in patients with colorectal cancer and unresectable liver-only metastasis

Jun Ho Ji, Se Hoon Park, Jeeyun Lee, +9

Cancer Chemotherapy and Pharmacology

Surgical OncologyGastrointestinal OncologyMedicineHepatobiliary TumorPathology +6

Effect of simvastatin plus cetuximab/irinotecan for KRAS mutant colorectal cancer and predictive value of the RAS signature for treatment response to cetuximab

Jeeyun Lee, Yong Sang Hong, Jung Yong Hong, +18

Investigational New Drugs

Ras SignatureMedicinePharmacologyTreatment ResponseColorectal Cancer +7